Purpose: Ultrasonographic contrast enhancement of carotid plaque (CECP) has been used to detect neovascularization of vasa vasorum and plaque. However, it is uncertain whether CECP can provide risk stratification of coronary artery disease (CAD). This study aimed to evaluate the relationship between CECP and manifestations of acute coronary syndrome (ACS) in established CAD patients and to explore the prognostic implication of CECP for cardiovascular (CV) clinical outcomes.Methods: A medical record review revealed that contrast-enhanced ultrasonography was performed to evaluate carotid atherosclerosis in 209 coronary artery-stented and 105 non-stented patients. The rate of ACS manifestations was compared depending on contrast uptake patterns: grade 0, absent; grade 1, dot; and grade 2, diffuse pattern. CV primary outcomes were assessed during a mean 7.6 months of follow-up.Results: Male sex, smoking, history of old myocardial infarction, intensive medications, and a favorable lipid profile were common in the stented versus non-stented group. Patients with grade 2 CECP had a higher rate of ACS, greater plaque thickness, and class I-II of Gray-Weale plaque echogenicity. During follow-up, 10 coronary revascularizations (nine ACSs), six strokes, and four heart failures occurred. Grade 2 CECP was more closely related with CV primary outcomes and showed a tendency toward more acute CV outcomes.Conclusion: ACS manifestations were proportionate to CECP grade. Diffuse CECP uptake could be a risk factor for acute CV outcomes. K E Y W O R D S acute coronary syndrome, carotid plaque, contrast-enhanced ultrasonography 1 | INTRODUCTION Contrast-enhanced ultrasonography (CEU) can not only clearly depict the carotid artery and its lesions, but also demonstrate neovascularization within carotid plaque. 1-3 Despite a lack of definitive evidence, ultrasonographic contrast-enhancement of carotid plaque (CECP) appears to be a marker of plaque vulnerability as it usually results from local inflammation, hemorrhage, or dissection. 1 Similarly, contrast uptake in the vasa vasorum could provide useful information about carotid atherosclerosis in its earliest stage, 4 and CECP has been related with subclinical or clinical cardiovascular (CV) events. 5,6Plaque histology has shown that the degree of CECP is related with the extent of neovascularization. 1,2 Diffuse or smoky rather than dot CECP patterns would be linked with extensive or hyperemic microvascularity. In vulnerable plaques, CEU may also be used to evaluate the effects of statins. 7 However, the relationship between CECP patterns and acute coronary syndrome (ACS) or chronic stable ischemic heart disease (IHD)